You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 1, January 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corneal Juvenile Xanthogranuloma in a 4-Month-Old Child

Arch Ophthalmol. 2003;121:117-118.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Juvenile xanthogranuloma (JXG) is a benign histiocytic disease of uncertain pathogenesis that usually appears as a cutaneous lesion(s) in the head and neck region of young children. Diagnosis is based on histological examination that shows a nodular, dense infiltrate of polygonal or spindled mononuclear cells with moderate amounts of cytoplasm and scattered Touton giant cells. Juvenile xanthogranulomas are typically positive for CD68 and factor XIIIa immunostains and are negative for CD1a and S100 protein; this information is helpful in differentiating JXG from other histiocytic proliferations.1 We present the case of a 4-month-old child with corneal JXG.

Report of a Case

The mother of a 4-month-old infant boy noted an enlarging, raised mass in the medial corner of his right eye. A biopsy performed by a local ophthalmologist was interpreted as noncaseating granulomatous inflammation. Despite normal findings on systemic evaluation, sarcoidosis was diagnosed. He received topical steroid therapy and was referred to us.

Examination of . . . [Full Text of this Article]


Comment
Corresponding author and reprints: Matthew W. Wilson, MD, Department of Ophthalmology, University of Tennessee Health Science Center, 956 Court Ave, D-228, Memphis, TN 38163 (e-mail: mwilson@mail.eye.utmem.edu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.